SCHEMBL6133099

SCHEMBL6133099

CC(=O)N1CC(=O)NC(Cc2cccc(NC(=O)OC(C)(C)C)c2)C1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY1R P25929 1/20 0.44
BRD4 O60885 3/20 0.43
CREBBP Q92793 3/20 0.43
HDAC6 Q9UBN7 3/20 0.39
PRMT5 O14744 1/20 0.39
WDR77 Q9BQA1 1/20 0.39
AURKA O14965 1/20 0.38
RPS6KB1 P23443 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C19 P33261 1/20 0.38
HCRTR1 O43613 1/20 0.37
HCRTR2 O43614 1/20 0.37
SIRT2 Q8IXJ6 1/20 0.37
HDAC1 Q13547 2/20 0.37
HDAC8 Q9BY41 2/20 0.37
CYP17A1 P05093 1/20 0.37
CCKBR P32239 1/20 0.36
DRD2 P14416 1/20 0.36
AKT1 P31749 1/20 0.36
USP30 Q70CQ3 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6132977 0.80 BRD4 (0.46) NPY1RBRD4CREBBPHDAC6PRMT5
SCHEMBL6132863 0.77 OPRK1 (0.44) HDAC6DRD2
SCHEMBL5557284 0.76 HDAC6 (0.45) HDAC6HDAC1HDAC8
SCHEMBL5557293 0.76 HDAC6 (0.45) HDAC6HDAC1HDAC8
SCHEMBL21583942 0.70 AURKA (0.48) NPY1RHDAC6PRMT5WDR77AURKA
SCHEMBL1985668 0.70 MAPT (0.54) HDAC6AURKARPS6KB1CYP3A4CYP2C19
SCHEMBL8711740 0.70 AURKA (0.50) NPY1RHDAC6PRMT5WDR77AURKA
SCHEMBL31139332 0.70 PDK1 (0.58) NPY1RHDAC6PRMT5WDR77AURKA
SCHEMBL1858721 0.70 PDK1 (0.58) NPY1RHDAC6PRMT5WDR77AURKA
SCHEMBL29991279 0.70 MAPT (0.54) HDAC6AURKARPS6KB1CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6924278-B2 Heterocyclic carboxy amines such as (2R)-1-[3,5-Bis(trifluoromethyl)benzoyl]-4-[4-((3S)-3-ethylmorpholino)-2-butynyl]-2-[(1H-indol-3-yl)methyl]piperazine, used as substance P and neurokinin antagonist for prophylaxis of diseases FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-08-02 US disclosed
US-20050027121-A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-02-03 US disclosed
US-20030114668-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-06-19 US disclosed
EP-0993457-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-04-19 EP disclosed
WO-1998057954-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050027121-A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists TAC3, TACR1, SSTR5 NPY1R 65/4885BRD4 1752/4885CREBBP 1619/4885
US-20030114668-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS TACR1, NPSR1, SSTR2 NPY1R 7/4885BRD4 1879/4885CREBBP 2398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.